New York Times Feed


    Takeda and Seattle Genetics Announce Positive Results from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (brentuximab vedotin) in Frontline Advanced Hodgkin LymphomaJune 27, 2017

    (ME NewsWire)-- Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that the Phase 3 ECHELON-1 clinical trial met its primary endpoint of a statistically significant improvement in modified progression-free survival (PFS) versus the control arm. ECHELON-1 is a randomized, multicenter trial evaluating ADCETRIS (brentuximab vedotin) as part of a frontline combination chemotherapy regimen in 1,334 patients with previously untreated advanced classical Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed to CD30, a defining marker of classical Hodgkin lymphoma. ADCETRIS is currently not approved as a frontline therapy for Hodgkin lymphoma. Patients in ECHELON-1 were randomized to receive either a combination of ADCETRIS+AVD (Adriamycin, vinblastine, dacarbazine) or ABVD (Adriamycin, bleomycin, vinblastine, dacarbazine), a recognized standard of care for frontline Hodgkin lymphoma. The results of the ECHELON-1 trial demonstrated that combination treatment with ADCETRIS resulted in a statistically significant......

    Continue Reading >
    Saudi Campaign provides medical aid to Syrians in Jordan via Moroccan hospital June 24, 2017

    The Saudi Specialized Clinics, which are among the most important relief activities of the Saudi National Campaign, have a good reputation among relief organizations working in the healthcare field around the world. Many international, regional, Arab and local organizations visit the clinics in order to learn about the services offered to the affected people and benefit from the scientific and practical expertise of the distinguished medical cadres working to provide the best medical treatment for Syrian refugees.


    Continue Reading >
    Acelity Strengthens Global Commercial Leadership; Names Ramesh Subrahmanian President for International Region June 24, 2017

    (ME NewsWire)-- Acelity L.P. Inc., a leading global advanced wound care company, today announced Ramesh Subrahmanian will join the company as President for the International region and member of the senior leadership team effective July 17th. Acelity recently appointed John McAuley as Senior Vice President for Europe.

    Subrahmanian brings more than 25 years of leadership experience in business development,"...

    Continue Reading >
    Takeda Presents Data from Phase 1/2 Studies for NINLARO™ (ixazomib) in Newly Diagnosed Multiple Myeloma Patients and in the Maintenance SettingJune 24, 2017

    – Early studies of weekly and twice-weekly ixazomib plus lenalidomide and dexamethasone demonstrate deep responses after induction, with deepening responses seen after single-agent ixazomib maintenance –

    – Data to be presented during two oral sessions at the 2017 European Hematology Association (EHA) Annual Meeting –


    Continue Reading >
    First-Ever World Kidney Cancer Q&A Day Highlights Growing Global BurdenJune 20, 2017

    (ME NewsWire)-- Kidney cancer is a silent disease that’s on the rise. The global incidence of kidney cancer is predicted to increase by a shocking 22 percent by 2020. Explanations are incomplete, but include risk factors such as aging, obesity, high blood pressure and smoking.

    The lack of answers is why the International Kidney Cancer Coalition (IKCC) and kidney cancer organisations worldwide are"...

    Continue Reading >
    New Study Compares Performance of Masimo Next Generation SedLine® Patient State Index (PSi) to Original PSi During AnesthesiaJune 20, 2017

    (ME NewsWire)-- Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at Euroanaesthesia 2017 in Geneva, Switzerland. In the study, researchers at University Medical Center Groningen, Netherlands, compared original and Next Generation versions of Masimo Patient State Index (PSi, a processed EEG parameter related to the effect of anesthetic agents) during Masimo SedLine® brain function monitoring of patients under propofol and sevoflurane anesthesia.1 SedLine brain function monitoring features four simultaneous EEG leads to enable continuous assessment of both sides of the brain, four EEG waveforms, a Density Spectral Array (DSA, an easy-to-interpret, high-resolution display of bi-hemispheric activity and EEG power), and PSi. Next Generation SedLine enhances PSi to make it less susceptible to electromyographic (EMG) interference and to improve its performance in low-power......

    Continue Reading >
    Regulations endorsed for establishment of private medical universities June 18, 2017

    The Higher Education Council (HEC) has recently endorsed a set of regulations for the establishment of private medical universities, according to Higher Education Minister Adel Tweisi.

    These regulations introduce conditions for the initial licensing of private medical universities in Jordan, he said on Saturday, explaining that there are currently four public universities offering medical programmes.


    Continue Reading >
    Sheyyab checks on health centres June 18, 2017

    Health Minister Mahmoud Sheyyab on Saturday checked on the quality of services provided by Marikh, Al Thraa Al Gharby and Taj health centres in Amman.

    During his visit to the Marikh centre, he called on stakeholders to search for another suitable building that can accommodate the increasing number of patients.

    Also on Saturday, Sheyyab headed a weekly meeting with the"...

    Continue Reading >
    Jordan participates in UN meeting on rights of persons with disabilitiesJune 15, 2017

    Jordan is participating in the10th session of the Conference of States Parties to the Convention on the Rights of Persons with Disabilities (CRPD), currently being held in New York.

    The meeting this year is held under the theme 'Inclusion and full participation of persons with disabilities and their representative organizations in the implementation of the Convention.' It aims at addressing the impact of multiple discrimination on persons with disabilities and promoting their participation. It is also"...

    Continue Reading >
    Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery June 12, 2017

    (ME NewsWire)-- GE Chairman and CEO Jeff Immelt announced today the appointment of Kieran Murphy as president and CEO of GE Healthcare, effective immediately. Murphy is currently president and CEO of GE Healthcare Life Sciences. Murphy succeeds John Flannery who has been appointed CEO and chairman elect of GE.

    Murphy, 54, was appointed CEO of GE Healthcare Life Sciences in September 2011. Since then, he"...

    Continue Reading >